Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Insider North Carolina.
Press releases published on June 17, 2025

Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone
MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the final assay results from the Southwest Zone (“Southwest”) as part of its ongoing 2025 Exploration …

Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest
MONTRÉAL, 17 juin 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (« Troilus » ou la « Société ») (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) a le plaisir d’annoncer les résultats d’analyse finaux provenant de la zone Southwest («Southwest») dans le cadre de sa …

Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia
Highlights Metallurgical testwork program with encouraging preliminary results including 89% average flotation recovery from 120-150µm grind size producing clean concentrate with grade of 20-25% Cu. Pre-concentration and heap leach testwork ongoing with …

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of …

Vireo Growth Inc. Provides Corporate Update Post Closing of All Merger Transactions
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced a series of corporate updates following the closing of all its previously-announced definitive merger agreements, which …

Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it was …

Inventus Reports Additional High-Grade Confirmation Drilling and Commences Bulk Sample Extraction at the Pardo Gold Project
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce additional high-grade assay results from grade-control drilling at Trench 1, as well as the commencement of bulk sample …

Material Update on Off-Market Takeover by Bastion Mining
TORONTO, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) today provides an important update in relation to the off-market takeover offer by Bastion Mining Pte. Ltd. UEN 202512367N (Bastion) to acquire …

Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project
Locked cycle tests exceed 90% copper and molybdenum recoveries and confirm clean final products with high separation efficiency Vancouver, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) …

Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhibiting at European Society of Organ Transplantation (ESOT) …

Fountain Asset Corp. Announces Normal Course Issuer Bid
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Fountain Asset Corp. (TSXV: FA) (“Fountain”) announced today its intention to effect a normal course issuer bid through the facilities of the TSX Venture Exchange, subject to receipt of regulatory approval. Upon …

Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – – Lorundrostat showed a clinically meaningful reduction in …

Canadian Cannabis Companies Go Global Amid Rising Export Demand
Toronto, ON, June 17, 2025 (GLOBE NEWSWIRE) -- Canada is a global leader in regulated medical cannabis exports with federal legalization reinforcing its position on the international stage and giving producers a strong advantage abroad. But as global …

Beneficient Announces Court Approval of GWG Litigation Settlement
DALLAS, June 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Beneficient,” “Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of …

OROCO ANNOUNCES PRIVATE PLACEMENT
VANCOUVER, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) of up to 5,000,000 units of the Company (each, a “Unit”) …

Mobilicom to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24–25, 2025
Mobilicom’s corporate presentation and investment thesis can be viewed here: LINK Palo Alto, California, June 17, 2025 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, today …

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer
Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in combination with either pembrolizumab or cetuximab as a strategy to overcome tumor resistance REHOVOT, Israel, June 17, 2025 (GLOBE …

ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
CAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies selective for toxic oligomers associated with …

Antalpha Reports First Quarter 2025 Results
SINGAPORE, June 17, 2025 (GLOBE NEWSWIRE) -- - Antalpha Platform Holding Company (“Antalpha” or the “Company”) (NASDAQ: ANTA), a leading fintech platform serving the Bitcoin mining ecosystem, today announced its unaudited financial results for the first …

Die Hauptkonferenz des 17. Straits Forums wurde in Xiamen, Fujian, eröffnet
XIAMEN, China, June 17, 2025 (GLOBE NEWSWIRE) -- Am 15. Juni fand in Xiamen in der Provinz Fujian die Hauptkonferenz des 17. Straits Forum statt. Seit seiner Einführung im Jahr 2 009 hat das Forum mit der Mission, den Austausch zwischen den Menschen auf …